• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Exemestane
    3 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Aromasin
    Pfizer
    RX
    partial basket chart
    Aromasin

    Aromatase Inhibitor. Exemestane 25 mg.
    TABS: 30. 1 tab (25 mg) dly. aft. meals.
    See lit.
    Advanced breast cancer (ABC) in women
    with natural/induced post-menopaus.
    status (progress. foll. anti-estrogen ther.
    alone) and in post-menopaus. women
    (progress. foll. multiple hormonal
    therapies). Adjuv. tmt post-menopaus.
    women with estrogen receptor pos. invas.
    early breast cancer foll. 2-3 yrs of initial
    adjuv. ther.
    C/I: Hypersens., premenopaus., pregn.,
    lact.

    Exemasin-Vit 25 mg
    Vitamed
    RX
    partial basket chart
    Exemasin-Vit 25 mg

    Aromatase Inhibitor. Exemestane 25 mg.
    COAT. TABS.:30. One tab. (25 mg)×1/d. See lit.
    Tmt. of advanced breast cancer (ABC) in women with natural or induced postmenopaus. status whose disease has progres. follow. anti-oestrogen ther. alone. Tmt. of postmenopaus. women with ABC whose dis. has progres. follow. multiple hormone. therapies.
    Indicated for the adjuvant tmt. of postmenopaus. women with oestrogen receptor positive invas. early breast cancer follow. 2-3 years of init. adjuvant tamoxifen ther.
    C/I: Hypersens. Pregnancy. Lactation.
    Women of child bear. potential.

    Exemestane Teva
    Abic
    RX
    partial basket chart
    Exemestane Teva

    Aromatase Inhibitor. Exemestane 25 mg.
    F.C.TABS: 25 mg: x 10, 14, 15, 20, 28, 30,
    50, 60, 90, 98, 100, 120 tab.
    1 tab (25 mg) dly. aft. meals.
    Tmt. of advanced breast cancer (ABC) in
    women with nat./ induc. postmenopaus.
    status (progress. foll. anti-estrogen ther.
    alone); Tmt. of postmenopaus. women
    with ABC whose disease has progress. foll.
    multiple hormonal ther. Adjuv. tmt. of postmenopaus. women with estrogen
    receptor pos. invas. early breast cancer foli.
    2-3 years of initial adjuv. tamoxifen ther.
    C/I: Hypersens., premenopaus., pregn.,
    lact.

    CLOSE